Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rubin

Showing results (1091-1100 of 1,437) with videos related to

Pageof 144
Sort By:
European Journal of Pharmacology|August 4, 2004
Alpha 2-adrenoceptors and 5-HT receptors mediate the antinociceptive effect of new pyrazolines, but not of dipyroneMaria Celoni M Godoy, Michele R Fighera, Fabiane R Souza, et al.
American Journal of Preventive Medicine|April 23, 2016
Economic Analysis of Veterans Affairs Initiative to Prevent Methicillin-Resistant Staphylococcus aureus InfectionsRichard E Nelson, Vanessa W Stevens, Karim Khader, et al.
Cancer Research|April 16, 2009
Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapyMara P Steinkamp, Orla A O'Mahony, Michele Brogley, et al.
Neoplasia (New York, N.Y.)|September 3, 2009
RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer diseaseKilian M Gust, Matthias D Hofer, Sven R Perner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 9, 2000
Autologous stem cell transplantation for acute myeloid leukemia in first remissionC A Linker, C A Ries, L E Damon, et al.
Cancer Discovery|April 16, 2017
Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate CancerMin Zou, Roxanne Toivanen, Antonina Mitrofanova, et al.
Life Sciences|October 14, 2008
Antinociceptive action of 4-methyl-5-trifluoromethyl-5-hydroxy-4, 5-dihydro-1H-pyrazole methyl ester in models of inflammatory pain in miceJulie Milano, Mateus F Rossato, Sara M Oliveira, et al.
Neuro-Oncology|September 20, 2022
Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-β signaling in recurrent tumorsElham Kashani, Désirée Schnidrig, Ali Hashemi Gheinani, et al.
Cancer Research|December 14, 2011
Common structural and epigenetic changes in the genome of castration-resistant prostate cancerTerence W Friedlander, Ritu Roy, Scott A Tomlins, et al.
Cancer|August 3, 1999
The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9J M McKiernan, R Buttyan, N H Bander, et al.
Pageof 144

Showing results (1091-1100 of 1,437) with videos related to

Sort By:
Pageof 144
European Journal of Pharmacology|August 4, 2004
Alpha 2-adrenoceptors and 5-HT receptors mediate the antinociceptive effect of new pyrazolines, but not of dipyroneMaria Celoni M Godoy, Michele R Fighera, Fabiane R Souza, et al.
American Journal of Preventive Medicine|April 23, 2016
Economic Analysis of Veterans Affairs Initiative to Prevent Methicillin-Resistant Staphylococcus aureus InfectionsRichard E Nelson, Vanessa W Stevens, Karim Khader, et al.
Cancer Research|April 16, 2009
Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapyMara P Steinkamp, Orla A O'Mahony, Michele Brogley, et al.
Neoplasia (New York, N.Y.)|September 3, 2009
RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer diseaseKilian M Gust, Matthias D Hofer, Sven R Perner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 9, 2000
Autologous stem cell transplantation for acute myeloid leukemia in first remissionC A Linker, C A Ries, L E Damon, et al.
Cancer Discovery|April 16, 2017
Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate CancerMin Zou, Roxanne Toivanen, Antonina Mitrofanova, et al.
Life Sciences|October 14, 2008
Antinociceptive action of 4-methyl-5-trifluoromethyl-5-hydroxy-4, 5-dihydro-1H-pyrazole methyl ester in models of inflammatory pain in miceJulie Milano, Mateus F Rossato, Sara M Oliveira, et al.
Neuro-Oncology|September 20, 2022
Integrated longitudinal analysis of adult grade 4 diffuse gliomas with long-term relapse interval revealed upregulation of TGF-β signaling in recurrent tumorsElham Kashani, Désirée Schnidrig, Ali Hashemi Gheinani, et al.
Cancer Research|December 14, 2011
Common structural and epigenetic changes in the genome of castration-resistant prostate cancerTerence W Friedlander, Ritu Roy, Scott A Tomlins, et al.
Cancer|August 3, 1999
The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9J M McKiernan, R Buttyan, N H Bander, et al.
Pageof 144